Mark Babbitt joins Jim Blasingame to discuss the unprecedented sources of uncertainty in our lives and business operation and recommend some ways to manage those challenges.

Mark Babbitt joins Jim Blasingame to recommend that small business owners continue their leadership roles in their communities during these challenging times, and why that will set them apart with employees and customers.

Doug Wead joins Jim Blasingame to discuss the bankrupt practices of the mainstream media and their corrupt reporting that should worry every American regardless of whether they are helping your candidate or not.

Doug Wead joins Jim Blasingame to discuss the enigma that is Donald Trump and how in the face of his personal behavior and multiple assaults, some unjustified, he has created an almost unprecedented list of results.

Doug Wead joins Jim Blasingame to discuss his ideas on what President Trump is up against to win reelection, and what’s at stake for America either way.

Ed Marsh joins Jim Blasingame to discuss that the political response to the coronavirus pandemic did not rely enough on the ability of business owners and citizens to manage risk and uncertainty without the heavy hand of government.

Ed Marsh joins Jim Blasingame to discuss the power of diversity and redundancy in our acquisition and supply chain decisions, plus Jim recognizes Ed’s son Owen as one of many U.S. men and women standing a post today in harm’s way.

Leslie Grossman, Joan Pryde and Karen Cortell Reisman join Jim to begin the celebration as breast cancer survivors and honor the lost, by telling their diagnosis and subsequent journey.

Leslie Grossman, Joan Pryde and Karen Cortell Reisman join Jim to share the stories of their journey as breast cancer survivors and to encourage women to take all the steps that are required to survive, especially taking those steps during a pandemic.

Leslie Grossman, Joan Pryde and Karen Cortell Reisman join Jim to tell their survivor’s journey stories and how they moved forward after being diagnosed, receiving treatment, and becoming a multi-year survivor.